Multiple metastasis of follicular variant of papillary thyroid carcinoma coexistent with malignant melanoma
Yu Ji Kim, Kyung Ae Lee, Tae Sun Park, Hong Sun Baek, Heung Yong Jin
Korean J Intern Med. 2018;33(3):634-637. Published online January 16, 2017
|
|
Hemato-oncology
Treatment outcomes and clinical relevance of the
Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients
treated with chemotherapy
Chi Hoon Maeng, Sung Woo Ahn, Seong-Yoon Ryu, Sungjun Han, Young Hyeh Ko, Jun Ho Ji, Won Seog Kim, Seok Jin Kim
Korean J Intern Med. 2016;31(3):560-569. Published online February 22, 2016
Background/Aims: The Follicular Lymphoma International Prognostic Index (FLIPI) and FLIPI2 are well-known prognostic models for patients with follicular lymphoma (FL). However, their prognostic relevance has not been examined before in Korean patients with FL.
Methods: We reviewed clinical and labo..
|
|
Endocrinology-metabolism
Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data
Won Gu Kim, Tae Yong Kim, Tae Hyuk Kim, Hye Won Jang, Young Suk Jo, Young Joo Park, Sun Wook Kim, Won Bae Kim, Minho Shong, Do Joon Park, Jae Hoon Chung, Young Kee Shong, Bo Youn Cho
Korean J Intern Med. 2014;29(3):325-333. Published online April 29, 2014
Background/Aims: Follicular thyroid carcinoma (FTC) and Hurthle cell carcinoma (HCC) of the thyroid are relatively uncommon thyroid malignancies in iodine- sufficient areas. In this study we evaluated the clinical behavior, prognostic factors and treatment outcomes of FTC and HCC in Korea.
|
|
Two Cases of Interstitial Pneumonitis Caused by Rituximab Therapy
Yuna Lee, Sun Young Kyung, Soo Jin Choi, Soo-Mee Bang, Seong Hwan Jeong, Dong Bok Shin, Jae Hoon Lee
Korean J Intern Med. 2006;21(3):183-186. Published online September 30, 2006
Rituximab, a chimeric monoclonal antibody directed against CD20, has become a part of the standard therapy for patients with non-Hodgkin's lymphoma either in combination with other drugs or as a single agent. The CD20 antigen is expressed on 95% of B-cell lymphoma cells and normal B-cells but, is..
|
|
A Patient with Primary Squamous Cell Carcinoma of the Thyroid Intermingled with Follicular Thyroid Carcinoma that Remains Alive more than 8 Years after Diagnosis
Tae Sik Jung, Young Lyun Oh, Young-Ki Min, Myung-Shik Lee, Moon-Kyu Lee, Kwang-Won Kim, Jae Hoon Chung
Korean J Intern Med. 2006;21(1):73-78. Published online March 30, 2006
Primary squamous cell carcinoma of the thyroid is an extremely rare tumor with a highly aggressive clinical course. We report here on a patient with primary squamous cell carcinoma of the thyroid who remains alive more than 8 years after diagnosis. A 56-year-old man presented with a hoarse voice ..
|
|
|